# A Phase 1 Study of CNTO 3157 in Healthy Volunteers and Patients With Asthma

> **NCT01195207** · PHASE1 · COMPLETED · sponsor: **Centocor, Inc.** · enrollment: 79 (actual)

## Conditions studied

- Asthma

## Interventions

- **BIOLOGICAL:** CNTO 3157 or placebo
- **BIOLOGICAL:** CNTO 3157 or placebo
- **BIOLOGICAL:** CNTO 3157 or placebo
- **BIOLOGICAL:** CNTO 3157 or placebo
- **BIOLOGICAL:** CNTO 3157 or placebo
- **BIOLOGICAL:** CNTO 3157 or placebo
- **BIOLOGICAL:** CNTO 3157 or placebo
- **BIOLOGICAL:** CNTO 3157 or placebo

## Key facts

- **NCT ID:** NCT01195207
- **Lead sponsor:** Centocor, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** —
- **Final completion:** 2012-01
- **Target enrollment:** 79 (ACTUAL)
- **Last updated:** 2012-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01195207

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01195207, "A Phase 1 Study of CNTO 3157 in Healthy Volunteers and Patients With Asthma". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01195207. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*